Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × immunotoxin HA22 × Lymphoid × Clear all

Sponsor

Cancer Type

Other hematologic neoplasm 1

Interventions

Rituximab 17 Cyclophosphamide 11 zanubrutinib 7 Bendamustine Hydrochloride 7 obinutuzumab 6 Vincristine 6 Lenalidomide 6 venetoclax 5 fludarabine 5 blinatumomab 5 acalabrutinib 5 Prednisone 4 Methotrexate 4 Doxorubicin 4 Cytarabine 4 Brentuximab Vedotin 4 tisagenlecleucel 3 pegaspargase 3 ibrutinib 3 axicabtagene ciloleucel 3 tafasitamab 2 prednylidene 2 polatuzumab vedotin 2 pirtobrutinib 2 merphos 2 idelalisib 2 duvelisib 2 deltacortene 2 avapritinib 2 asparaginase erwinia chrysanthemi recombinant 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡